Core Insights - The company is undergoing a transformative restructuring effort aimed at revitalizing its business, which includes rebuilding culture, restoring operational discipline, and modernizing core systems [2] - The company reported total revenue of $8.9 million in the fourth quarter of fiscal 2025, an increase from $7.3 million in the same quarter of fiscal 2024 [4] - The company experienced a net loss from continuing operations of $2.9 million or $(0.37) per share in the fourth quarter of fiscal 2025, compared to a net loss of $1.6 million or $(0.25) per share in the fourth quarter of fiscal 2024 [12][16] Financial Performance - Total revenue for fiscal 2025 was $29.6 million, compared to $28.0 million in fiscal 2024 [12] - Total costs and expenses increased to $35.5 million in fiscal 2025 from $32.9 million in fiscal 2024, primarily due to inflationary pressures and higher raw material costs [12] - The company reported a net loss from continuing operations of $6.1 million or $(0.86) per share for fiscal 2025, compared to a net loss of $4.9 million or $(0.77) per share for fiscal 2024 [12][16] Operational Highlights - The company has retired its co-packing operations in Salt Lake City and adjusted or exited unprofitable Specialty Market relationships [5] - A new store was opened in Charleston, South Carolina, under refreshed branding and design, with plans for a flagship location in downtown Chicago [5] - The company is advancing its brand modernization efforts, including a refreshed store design, signage upgrades, and a redesigned website expected to launch in July 2025 [5][6] Strategic Initiatives - The company has implemented a rational franchise product pricing model effective March 1, 2025, to address systemic margin pressures [5] - The company is focused on disciplined growth and profitability for the remainder of fiscal 2026, emphasizing improved franchisee performance [2] - A brand refresh is underway, including a new logo and upgraded digital experience set to launch in the coming months [2]

NEW YORK, June 17, 2025 /PRNewswire/ -- W. P. Carey (W. P. Carey, NYSE: WPC), a leading net lease REIT specializing in corporate sale-leasebacks, build-to-suits and the acquisition of single-tenant net lease properties, today announced the release of its 2024 Corporate Responsibility Report. Prepared in reference to disclosure standards established by the Task Force on Climate-related Financial Disclosures (TCFD) and Global Reporting Initiative (GRI), the report summarizes W. P. Carey's progress and achieve ...

– Veteran executive with over 20 years of oncology leadership and clinical experience with proven track record of success in bringing development candidates through late-stage clinical development – – Company will hold a conference call on July 29 at 4:30 p.m. ET/1:30 p.m. PT to share additional clinical data from its randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer (“mCRC”) – SAN DIEGO, June 17, 2025 (GLOBE ...

CONSHOHOCKEN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on June 15, 2025 to 36 new non-executive employees as equity inducement awards under the terms of Madrigal’s 2023 Inducement Plan. The equity awards were approved by Madrigal’s independent Compensation Committee in accordance with Nasdaq ...

Evan Bailey, MD, promoted to Chief Medical Officer, succeeding Riccardo Perfetti, MD, PhDDottie Caplan promoted to Executive Vice President, Patient Advocacy and Government Affairs NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced key appointments to its executive leadership team with the promotions of Evan Bailey, MD, to Chief Medical Officer (CMO), effective Ju ...

Company to be Renamed “BCP Investment Corporation” and Trade Under New Ticker “BCIC” Transition to Paying the Quarterly Base Distribution Monthly in 2026 Company, Management, Adviser and Other Affiliates Intend to Acquire up to 20% of Common Shares Over Next 24 Months to the Extent the Stock Trades Below 80% of NAV NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (NASDAQ: PTMN) (“Portman Ridge” or “PTMN”), today announced several updates and initiatives, aimed at enhancing shar ...

Joby Aviation TodayJOBYJoby Aviation$8.66 -0.34 (-3.78%) 52-Week Range$4.66▼$10.72Price Target$9.33Add to WatchlistRecent trading in Joby Aviation NYSE: JOBY shares highlights a sharp divide between short-term market noise and the company’s long-term progress. The stock took a noticeable dip after one of Joby’s market analysts issued a downgrade, creating a wave of caution through the retail investment community. This view, however, clashes with a powerful string of fundamental wins for the company. A rece ...

CHICAGO, June 17, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the second quarter of 2025 before the markets open on Wednesday, July 23, 2025. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.A live audio Webcast of the conference ca ...

Revenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024 Expect to report revenue of at least $1.7 million for quarter ending June 30, 2025, and introducing revenue guidance of $12-$16 million for the full fiscal year 2026 Submitted PMA supplement for second-generation LungFit® PH to FDA International distribution partnerships now provide access to markets representing over 2 billion lives, with LungFit® PH actively shipping to Europe, Australia, and the ...

Key Takeaways CVS stock has jumped 53.7% in 2025 on strong operations and a friendlier regulatory landscape. Removal of PBM and Medicare Advantage cuts boosts CVS' Caremark and Aetna business lines. CVS' digital care push, cost savings and expanded access are reinforcing its 2025 growth trajectory.CVS Health (CVS) has seen its stock surge by 53.7% in 2025, fueled by a potent combination of strong operational performance and a favorable regulatory outlook. The company raised its full-year 2025 EPS guidance ...